First Financial Bank – Trust Division Lowered Its Bristol (BMY) Position; 3par (PAR)’s Sentiment Is 2

January 2, 2018 - By Louis Casey

First Financial Bank – Trust Division decreased Bristol (BMY) stake by 65.07% reported in 2017Q3 SEC filing. First Financial Bank – Trust Division sold 107,846 shares as Bristol (BMY)’s stock declined 1.04%. The First Financial Bank – Trust Division holds 57,883 shares with $3.69M value, down from 165,729 last quarter. Bristol now has $100.30 billion valuation. The stock decreased 0.79% or $0.49 during the last trading session, reaching $61.28. About 3.95M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 2, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

PAR Technology Corporation, together with its subsidiaries, provides management technology solutions worldwide. The company has market cap of $149.67 million. The firm operates through two divisions, Restaurant/Retail and Government. It has a 48.2 P/E ratio. The Restaurant/Retail segment offers cloud and on-premise software applications and hardware platforms, as well as related installation, technical, and maintenance support services.

Friedberg Investment Management holds 0.64% of its portfolio in PAR Technology Corporation for 37,850 shares. Perritt Capital Management Inc owns 123,248 shares or 0.34% of their US portfolio. Moreover, Ancora Advisors Llc has 0.11% invested in the company for 189,787 shares. The California-based Eam Investors Llc has invested 0.09% in the stock. Rbf Capital Llc, a California-based fund reported 70,685 shares.

The stock increased 1.19% or $0.11 during the last trading session, reaching $9.35. About 16,161 shares traded. PAR Technology Corporation (PAR) has risen 84.63% since January 2, 2017 and is uptrending. It has outperformed by 67.93% the S&P500.

First Financial Bank – Trust Division increased Ishares (EFA) stake by 31,814 shares to 656,845 valued at $44.98 million in 2017Q3. It also upped Vanguard (VNQ) stake by 12,746 shares and now owns 200,558 shares. Ishares (QUAL) was raised too.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It improved, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. 832,222 were reported by Keybank National Association Oh. Mason Street Advsrs Ltd Liability Com invested in 0.36% or 227,652 shares. 2,005 are owned by Blume Cap Management. Merriman Wealth Ltd Liability holds 3,443 shares. California-based Polaris Greystone Grp Limited Liability Company has invested 1.65% in Bristol-Myers Squibb Company (NYSE:BMY). 39,761 are held by Planning Advisors Limited Co. Cypress Cap Group Inc accumulated 70,021 shares. Grimes & Communication Incorporated reported 8,111 shares or 0.05% of all its holdings. Washington Tru Comml Bank holds 5,944 shares. Savings Bank Of The Ozarks reported 61,899 shares. Kahn Brothers De invested in 19,050 shares or 0.19% of the stock. Headinvest Ltd Liability holds 0.25% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 12,775 shares. Moody State Bank Trust Division invested 0.02% in Bristol-Myers Squibb Company (NYSE:BMY). Winch Advisory Services Limited Liability Corporation has invested 0% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Tortoise Management Limited Liability Com has invested 0.05% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY).

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. On Thursday, July 27 the stock rating was maintained by Leerink Swann with “Buy”. On Monday, May 23 the stock rating was initiated by Hilliard Lyons with “Neutral”. BMO Capital Markets maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Sunday, July 23. BMO Capital Markets has “Sell” rating and $4700 target. On Thursday, August 11 the stock rating was downgraded by Berenberg to “Hold”. The firm has “Hold” rating by Jefferies given on Thursday, July 14. UBS maintained the stock with “Buy” rating in Friday, October 6 report. The firm has “Buy” rating by Jefferies given on Monday, July 17. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Jefferies on Tuesday, June 14. The company was maintained on Wednesday, August 16 by Credit Suisse. Cowen & Co maintained it with “Hold” rating and $6500 target in Monday, July 10 report.

Since September 6, 2017, it had 1 insider buy, and 2 selling transactions for $646,385 activity. Caldarella Joseph C also sold $560,400 worth of Bristol-Myers Squibb Company (NYSE:BMY) on Wednesday, September 6. $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) was sold by Lynch Thomas J. Jr. on Tuesday, December 12. 4,000 shares were bought by Samuels Theodore R. II, worth $249,187 on Friday, December 15.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on January, 25. They expect $0.67 earnings per share, up 6.35% or $0.04 from last year’s $0.63 per share. BMY’s profit will be $1.10 billion for 22.87 P/E if the $0.67 EPS becomes a reality. After $0.75 actual earnings per share reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -10.67% negative EPS growth.